Privação de sono total na doença de Parkinson
Open Access
- 1 September 1987
- journal article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 45 (3) , 224-230
- https://doi.org/10.1590/s0004-282x1987000300002
Abstract
Twelve Parkinson disease (PD) patients were submitted to a single night of total sleep deprivation (SD). Disease duration had a median of 5.1 years and all were using either anticholinergic or L-Dopa or the combination of both drugs. After SD there was an improvement of rigidity, bradykinesia, gait and posture disturbances and functional disability that remained significant for 2 weeks. No effect was observed on tremor. Concerning depressive symptoms, a significant difference was noted, that remained for one week. These results suggest that SD may be an useful procedure to improve PD symptomatology. It is discussed a possible change of dopaminergic receptors, induced by SD, to explain the improvement.Keywords
This publication has 21 references indexed in Scilit:
- Increased responsiveness to apomorphine after REM sleep deprivation: supersensitivity of dopamine receptors or increase in dopamine turnover?Journal of Pharmacy and Pharmacology, 1981
- REM sleep deprivation changes behavioral response to catecholaminergic and serotonergic receptor activation in ratsPharmacology Biochemistry and Behavior, 1981
- Does REM Sleep Deprivation Induce a Supersensitivity of Dopaminergic Receptors in the Rat Brain?Pharmacology, 1978
- Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depressionPsychopharmacology, 1977
- ENVIRONMENTAL AND DRUG INTERFERENCE WITH EFFECTS OF MARIHUANA*Annals of the New York Academy of Sciences, 1976
- The Treatment of Psychotic Depression by Sleep Deprivation: A Replication StudyThe British Journal of Psychiatry, 1975
- Catecholamine metabolism of manic-depressive illnessJournal of Psychiatric Research, 1968
- 5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASESThe Lancet, 1966
- Clinical experience with dihydroxyphenylalanine (DOPA) in depressionJournal of Psychiatric Research, 1963
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960